跳至主要内容
临床试验/CTRI/2026/02/104287
CTRI/2026/02/104287尚未招募2 期

A Comparative Clinical trial to evaluate the efficacy of Lekhaniya Mahakashaya based Ghanvati and Siddha Taila Uttarbasti in the management of Garbhashayagata Arbuda with special reference to Uterine Fibroid.

State Ayurvedic College and Hospital, Lucknow1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2026年4月1日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
40
试验地点
1

研究概览

简要总结

This is a Randomised, comparative clinical study Phase 2 Parallel group trial. Comparing the efficacy of Lekhaniya Mahakashaya based Ghanvati and Siddha Taila Uttarbasti in the management of Garbhashayagata Arbuda with special reference to Uterine Fibroid for 3 months in 40 patients. The patient fulfilling the clinical criteria for diagnosis of Garbhashayagata Arbuda will be randomly selected from OPD/IPD of state Ayurvedic College and Hospital, Lucknow and referred cases from other hospitals. A careful history, physical examination and necessary investigation will be performed. Further patient divided into two groups, Group-A- In this group patients will be treated with Lekhaniya Mahakashaya based Ghanvati orally 2 Ghanvati BD Pragbhukata with Ushnodaka Anupana for the period of 3 months. Group-B- In this group patients will be treated with Lekhaniya Mahakashaya based Ghanvati orally 2 Ghanvati BD Pragbhukata with Ushnodaka Anupana for the period of 3 months along with  Lekhaniya Mahakashaya Siddha Taila Uttarbasti of 3-5 ml by intra-uterine route for the period of 3 days  for 3 consecutive cycles after the clearance of menses. Follow up period will be 30 days after the completion of trial.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
22.00 Year(s) 至 45.00 Year(s)(—)
性别
Female

入选标准

  • Married female of age group between 22 to 45 years
  • Patients having Fibroid size less than or equal to 5 centimeter as per USG report with or without associated symptoms
  • Single or multiple Fibroids upto 3
  • Patients willing to participate and giving informed consent.

排除标准

  • Married female below the age of 22 and above the age of 45 years
  • Patient having Fibroid size more than 5cm and number of Fibroids more than 3 as per USG report
  • Patients having Submucosal Fibroids
  • Pregnant women and lactating mothers
  • Patient coming with Hb less than 9 gm per dl
  • Patient using intra-uterine contraceptive device or taking OCPs
  • Patient suffering from any other pelvic pathology like Ovarian tumour, Tubo ovarian mass, Endometriosis, PID, Malignancy, Cervical Polyp etc
  • Patient suffering from any systemic illness like Hypertension, Tuberculosis, Cardiac disorders, etc
  • Patients with acute and chronic inflammatory disease eg- UTI, HIV, HBsAg, VDRL, HCV etc.

研究者

发起方
State Ayurvedic College and Hospital, Lucknow
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Vertika Chaturvedi

State Ayurvedic College and Hospital, Lucknow Uttar Pradesh

研究点 (1)

Loading locations...

相似试验